Evaluating the Abuse Potential of Lenabasum, a Selective Cannabinoid Receptor 2 Agonist - Rachel Luba; Gabriela Madera; Rebecca Schusterman; Andrew Kolodziej; Ian Hodgson; Sandra D. Comer (The Journal of Pharmacology and Experimental Therapeutics, 2024)